Author: Cárdenas, Graciela; Torres-GarcÃa, Diana; Cervantes, Jaquelynne; Rosales-Mendoza, Sergio; Fleury, Agnes; Fragoso, Gladis; Laclette, Juan Pedro; Sciutto, Edda
Title: Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with Sars-Cov-2 Infection Cord-id: g6gduktp Document date: 2020_10_26
ID: g6gduktp
Snippet: The Chinese outbreak of SARS-CoV-2 during 2019 has become pandemic and the most important concerns are the acute respiratory distress syndrome (ARDS) and hyperinflammation developed by the population at risk (elderly and/or having obesity, diabetes, and hypertension) in whom clinical evolution quickly progresses to multi-organ dysfunction and fatal outcome. Immune dysregulation is linked to uncontrolled proinflammatory response characterized by the release of cytokines (cytokines storm). A prope
Document: The Chinese outbreak of SARS-CoV-2 during 2019 has become pandemic and the most important concerns are the acute respiratory distress syndrome (ARDS) and hyperinflammation developed by the population at risk (elderly and/or having obesity, diabetes, and hypertension) in whom clinical evolution quickly progresses to multi-organ dysfunction and fatal outcome. Immune dysregulation is linked to uncontrolled proinflammatory response characterized by the release of cytokines (cytokines storm). A proper control of this response is mandatory to improve clinical prognosis. In this context, glucocorticoids are able to change the expression of several genes involved in the inflammatory response leading to an improvement in acute respiratory distress. Although there are contradictory data in the literature, in this report we highlight the potential benefits of glucocorticoids as adjuvant therapy for hyperinflammation control; emphasizing that adequate dosage, timing, and delivery are crucial to reduce the dysregulated peripheral-and neuro-inflammatory response with minimal adverse effects. We propose the use of the intranasal route for glucocorticoid administration, which has been shown to effectively control the neuro-and peripheral-inflammatory response using low doses without generating unwanted side effects.
Search related documents:
Co phrase search for related documents- aberrant inflammatory response and adaptive immunity: 1
- aberrant inflammatory response and lung inflammation: 1, 2
- acute respiratory distress and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute respiratory distress and administration route: 1, 2, 3, 4, 5, 6
- acute respiratory distress and administration route dose: 1
- acute respiratory distress and low inflammation grade: 1, 2, 3, 4
- acute respiratory distress and low medium: 1, 2, 3
- acute respiratory distress and low medium dose: 1
- acute respiratory distress and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- adaptive immunity and administration route: 1, 2
- adaptive immunity and administration route dose: 1
- adaptive immunity and administration route dose timing: 1
- adaptive immunity and low inflammation grade: 1, 2, 3, 4, 5, 6, 7
- adaptive immunity and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- administration route and lung inflammation: 1, 2, 3, 4, 5
- low inflammation grade and lung inflammation: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date